Researchers hope that tools like ChatGPT could be useful in helping find targets...
Wall Street is embracing health insurers after they scored a big win for Medicar...
A new AI tool called DeepGlioma aims to give surgeons a real-time way to test br...
Sharing health data with advertisers should be banned.
SynKIR-110 is an investigational drug to treat mesothelin-expressing mesotheliom...
The agreement will provide the company with additional capital for its growth tr...
Ginkgo will also receive StrideBio's existing library of capsids optimised for p...
LIVMARLI showed maintenance of treatment effect with sustained decrease in serum...
GRIA disorder is a family of rare genetic diseases triggered by mutations in the...
Everest’s NDA for Nefecon in China is anticipated to receive clearance by the se...
Biotheryx will receive up to $347m in potential future regulatory and commercial...
Shanghai Henlius Biotech, Accord’s business partner, originally developed HLX02.
After more than a decade, the FDA has updated its guidance for patient-focused d...
The UK’s MHRA gave a green light to the company to start a Phase IIb trial with ...
The Biden administration will soon crack down on Medicare Advantage insurers tha...
Three former executives at Magellan Diagnostics are charged with knowingly selli...
